Orbimed Advisors LLC Nevro Corp Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $48.1 Million - $76.4 Million	-1,357,691 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $4.32 Million - $7.37 Million	97,600 Added 7.75%	1,357,691 $77.4 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $25.2 Million - $32.1 Million	362,300 Added 40.35%	1,260,091 $109 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $26.6 Million - $37.6 Million	402,891 Added 81.41%	897,791 $62 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $40 Million - $45.1 Million	494,900	494,900 $45 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $127M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.